Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
Molecular and Cellular Pediatrics
|
May 4, 2025
Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators
Burkhard Tümmler, Sophia Theres Pallenberg, Anna-Maria Dittrich, et al.
ERJ Open Research
|
March 18, 2026
Long-term impact of elexacaftor/tezacaftor/ivacaftor on small and large airways in people with cystic fibrosis aged ≥6 years: 24-month real-world evidence from the German Cystic Fibrosis Registry
Stefanie Dillenhöfer, Katharina Schütz, Manuel Burkhart, et al.
The Lancet. Respiratory Medicine
|
June 3, 2026
Clinical characteristics and outcomes in the adult cystic fibrosis population in Europe from 2014 to 2024: analysis of the European Cystic Fibrosis Society Patient Registry
Annalisa Orenti, Kris De Boeck, Eitan Kerem, et al.
Plos One
|
December 30, 2014
Identification of neutrophil activation markers as novel surrogate markers of CF lung disease
Timo Rath, Lisa Zwaschka, Lisa Hage, et al.
ERJ Open Research
|
July 24, 2023
Risk factors for forced expiratory volume in 1 s decline in European patients with cystic fibrosis: data from the European Cystic Fibrosis Society Patient Registry
Elpis Hatziagorou, Steffen Fieuws, Annalisa Orenti, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 27, 2013
Is there evidence for correct diagnosis in cystic fibrosis registries?
Muriel Thomas, Lydie Lemonnier, Vincent Gulmans, et al.
Plos One
|
March 22, 2013
Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease
Timo Rath, Lisa Hage, Marion Kügler, et al.
The Lancet. Respiratory Medicine
|
April 19, 2020
Impact of COVID-19 on people with cystic fibrosis
Carla Colombo, Pierre-Régis Burgel, Silvia Gartner, et al.
The Lancet. Diabetes & Endocrinology
|
December 5, 2017
Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial
Manfred Ballmann, Dominique Hubert, Baroukh M Assael, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
August 17, 2017
Three-center feasibility of lung clearance index in infants and preschool children with cystic fibrosis and other lung diseases
Mirjam Stahl, Simon Y Graeber, Cornelia Joachim, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
Molecular and Cellular Pediatrics
|
May 4, 2025
Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators
Burkhard Tümmler, Sophia Theres Pallenberg, Anna-Maria Dittrich, et al.
ERJ Open Research
|
March 18, 2026
Long-term impact of elexacaftor/tezacaftor/ivacaftor on small and large airways in people with cystic fibrosis aged ≥6 years: 24-month real-world evidence from the German Cystic Fibrosis Registry
Stefanie Dillenhöfer, Katharina Schütz, Manuel Burkhart, et al.
The Lancet. Respiratory Medicine
|
June 3, 2026
Clinical characteristics and outcomes in the adult cystic fibrosis population in Europe from 2014 to 2024: analysis of the European Cystic Fibrosis Society Patient Registry
Annalisa Orenti, Kris De Boeck, Eitan Kerem, et al.
Plos One
|
December 30, 2014
Identification of neutrophil activation markers as novel surrogate markers of CF lung disease
Timo Rath, Lisa Zwaschka, Lisa Hage, et al.
ERJ Open Research
|
July 24, 2023
Risk factors for forced expiratory volume in 1 s decline in European patients with cystic fibrosis: data from the European Cystic Fibrosis Society Patient Registry
Elpis Hatziagorou, Steffen Fieuws, Annalisa Orenti, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 27, 2013
Is there evidence for correct diagnosis in cystic fibrosis registries?
Muriel Thomas, Lydie Lemonnier, Vincent Gulmans, et al.
Plos One
|
March 22, 2013
Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease
Timo Rath, Lisa Hage, Marion Kügler, et al.
The Lancet. Respiratory Medicine
|
April 19, 2020
Impact of COVID-19 on people with cystic fibrosis
Carla Colombo, Pierre-Régis Burgel, Silvia Gartner, et al.
The Lancet. Diabetes & Endocrinology
|
December 5, 2017
Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial
Manfred Ballmann, Dominique Hubert, Baroukh M Assael, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
August 17, 2017
Three-center feasibility of lung clearance index in infants and preschool children with cystic fibrosis and other lung diseases
Mirjam Stahl, Simon Y Graeber, Cornelia Joachim, et al.
Page
of 9